Director General, Employers Union of Innovative Pharmaceutical Companies INFARMA
Michal Byliniak has been involved with the pharmaceutical market for more than 15 years, gaining extensive managerial experience in distribution, reimbursement, clinical trials and registration of medicinal products.
He was president of the District Pharmacy Chamber in Warsaw for many years, as well as president of the EU Pharmaceutical Group. Since 2022, he has been Director General of the Association of Employers of Innovative Pharmaceutical Companies INFARMA.
He has experience working in the Polish health care system in various types of organizations, such as pharmacies, national wholesalers, pharmaceutical companies and consulting firms. He is the author of numerous studies related to the pharmaceutical sector.
You watching archival version of European Economic Congress
What you can do:
Go to the current edition page or Continue browsing